Antiverse and GlobalBio, Inc. extend collaboration to advance antibody cancer therapeutics
Project leveraged Antiverse’s AI-driven Antibody Discovery Platform and GlobalBio’s ALTHEA semisynthetic libraries
17-Oct-2023 -
Antiverse Ltd, a biotechnology start-up company developing a computational antibody drug discovery platform, and GlobalBio, Inc., an antibody engineering company developing methods to engineer improved and more developable therapeutic antibodies, announced they will be extending their ...
antibodies
artificial intelligence
cancer
+3